SAN DIEGO, Jan. 11, 2016 /PRNewswire/ -- Sirenas, LLC, an innovative drug discovery and early stage development company focused on first-in-class marine-inspired therapeutics for the treatment of cancer, announced today it is being featured at the Biotech Showcase™ 2016. The CEO and Founder, Eduardo Esquenazi, PhD will present on Tuesday at 9:00am Pacific Time at the Parc55 in San Francisco, CA.
About Sirenas, LLC
Named a San Diego Venture Group Top 30 "Cool Company", Sirenas has uniquely combined marine chemical diversity with adaptive molecular informatics and next generation synthetic chemistry to create the Atlantis™ Platform for drug discovery. Sirenas' lead molecule, SMD-5033, is a toxin with a novel mechanism of action currently being evaluated as an antibody-drug conjugate payload. The company aims to sustainably and efficiently uncover, catalogue and develop the high value chemical diversity of the ocean to address medical needs in cancer, infectious and neurological diseases. Sirenas is headquartered in San Diego, California and has a presence at JLABS San Diego. For more information about Sirenas, please visit SirenasMD.com.
Contact: Michelle David, (858) 909-5685, [email protected]
SOURCE Sirenas, LLC